ANIK logo

Anika Therapeutics (ANIK) Total Liabilities

Annual Total Liabilities

$58.37 M
-$5.20 M-8.18%

December 31, 2023


Summary


Performance

ANIK Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIKbalance sheetmetrics:

Quarterly Total Liabilities

$51.54 M
-$776.00 K-1.48%

September 30, 2024


Summary


Performance

ANIK Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIKbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

ANIK Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-8.2%-10.6%
3 y3 years-37.4%-18.0%
5 y5 years+279.5%+36.0%

ANIK Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-8.2%at low-24.2%at low
5 y5-year-37.4%+37.9%-66.1%+21.8%
alltimeall time-37.4%+3333.3%-66.1%+3121.3%

Anika Therapeutics Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$51.54 M(-1.5%)
Jun 2024
-
$52.32 M(-5.2%)
Mar 2024
-
$55.21 M(-5.4%)
Dec 2023
$58.37 M(-8.2%)
$58.37 M(+1.2%)
Sep 2023
-
$57.67 M(+5.1%)
Jun 2023
-
$54.87 M(-10.8%)
Mar 2023
-
$61.49 M(-3.3%)
Dec 2022
$63.56 M(+5.2%)
$63.56 M(+1.2%)
Sep 2022
-
$62.81 M(-7.6%)
Jun 2022
-
$67.97 M(+20.4%)
Mar 2022
-
$56.45 M(-6.6%)
Dec 2021
$60.45 M(-35.1%)
$60.45 M(-3.8%)
Sep 2021
-
$62.87 M(-17.6%)
Jun 2021
-
$76.33 M(-10.8%)
Mar 2021
-
$85.60 M(-8.2%)
Dec 2020
$93.20 M(+120.2%)
$93.20 M(-29.3%)
Sep 2020
-
$131.89 M(-13.3%)
Jun 2020
-
$152.08 M(+44.5%)
Mar 2020
-
$105.22 M(+148.6%)
Dec 2019
$42.33 M(+175.2%)
$42.33 M(+11.7%)
Sep 2019
-
$37.90 M(+4.1%)
Jun 2019
-
$36.42 M(-3.1%)
Mar 2019
-
$37.59 M(+144.4%)
Dec 2018
$15.38 M(-19.6%)
$15.38 M(+9.9%)
Sep 2018
-
$14.00 M(-25.6%)
Jun 2018
-
$18.81 M(-8.6%)
Mar 2018
-
$20.57 M(+7.5%)
Dec 2017
$19.13 M(+9.5%)
$19.13 M(-3.6%)
Sep 2017
-
$19.84 M(-4.9%)
Jun 2017
-
$20.87 M(+20.3%)
Mar 2017
-
$17.34 M(-0.8%)
Dec 2016
$17.47 M(-29.8%)
$17.47 M(+5.8%)
Sep 2016
-
$16.52 M(-9.8%)
Jun 2016
-
$18.32 M(-4.0%)
Mar 2016
-
$19.09 M(-23.3%)
Dec 2015
$24.90 M(+69.3%)
$24.90 M(+7.8%)
Sep 2015
-
$23.10 M(+32.4%)
Jun 2015
-
$17.44 M(+9.9%)
Mar 2015
-
$15.87 M(+7.9%)
Dec 2014
$14.71 M(-27.9%)
$14.71 M(-6.9%)
Sep 2014
-
$15.79 M(-5.4%)
Jun 2014
-
$16.70 M(-4.5%)
Mar 2014
-
$17.49 M(-14.3%)
Dec 2013
$20.41 M(-38.4%)
$20.41 M(-28.8%)
Sep 2013
-
$28.68 M(-1.0%)
Jun 2013
-
$28.96 M(+1.5%)
Mar 2013
-
$28.53 M(-13.9%)
Dec 2012
$33.14 M(-13.0%)
$33.14 M(+5.6%)
Sep 2012
-
$31.40 M(-11.9%)
Jun 2012
-
$35.63 M(+1.9%)
Mar 2012
-
$34.97 M(-8.2%)
Dec 2011
$38.08 M(-12.9%)
$38.08 M(+3.1%)
Sep 2011
-
$36.93 M(-8.3%)
Jun 2011
-
$40.26 M(-2.2%)
Mar 2011
-
$41.15 M(-5.9%)
Dec 2010
$43.75 M(-7.5%)
$43.75 M(-3.8%)
Sep 2010
-
$45.48 M(+2.7%)
Jun 2010
-
$44.29 M(-3.6%)
Mar 2010
-
$45.96 M(-2.8%)
Dec 2009
$47.29 M(+34.9%)
$47.29 M(+47.1%)
Sep 2009
-
$32.14 M(-3.8%)
Jun 2009
-
$33.42 M(-1.8%)
Mar 2009
-
$34.04 M(-2.9%)
Dec 2008
$35.06 M
$35.06 M(+20.8%)
DateAnnualQuarterly
Sep 2008
-
$29.02 M(-4.9%)
Jun 2008
-
$30.51 M(+17.0%)
Mar 2008
-
$26.09 M(+6.3%)
Dec 2007
$24.54 M(+8.4%)
$24.54 M(-14.2%)
Sep 2007
-
$28.61 M(+13.0%)
Jun 2007
-
$25.32 M(+15.7%)
Mar 2007
-
$21.88 M(-3.3%)
Dec 2006
$22.63 M(-8.5%)
$22.63 M(-7.9%)
Sep 2006
-
$24.57 M(-0.1%)
Jun 2006
-
$24.60 M(+7.0%)
Mar 2006
-
$22.98 M(-7.1%)
Dec 2005
$24.73 M(-15.2%)
$24.73 M(-4.0%)
Sep 2005
-
$25.76 M(+2.2%)
Jun 2005
-
$25.20 M(-8.8%)
Mar 2005
-
$27.64 M(-5.3%)
Dec 2004
$29.18 M(+650.2%)
$29.18 M(+11.4%)
Sep 2004
-
$26.18 M(+9.8%)
Jun 2004
-
$23.84 M(-11.4%)
Mar 2004
-
$26.92 M(+592.1%)
Dec 2003
$3.89 M(+28.6%)
$3.89 M(+49.4%)
Sep 2003
-
$2.60 M(+21.9%)
Jun 2003
-
$2.13 M(-17.8%)
Mar 2003
-
$2.60 M(-14.1%)
Dec 2002
$3.02 M(+7.5%)
$3.02 M(-14.2%)
Sep 2002
-
$3.52 M(+14.6%)
Jun 2002
-
$3.07 M(+9.6%)
Mar 2002
-
$2.80 M(-0.3%)
Dec 2001
$2.81 M(+24.1%)
$2.81 M(-14.0%)
Sep 2001
-
$3.27 M(-13.3%)
Jun 2001
-
$3.77 M(+59.4%)
Mar 2001
-
$2.36 M(+4.3%)
Dec 2000
$2.27 M(-66.7%)
$2.27 M(-64.1%)
Sep 2000
-
$6.32 M(-13.6%)
Jun 2000
-
$7.31 M(-0.3%)
Mar 2000
-
$7.33 M(+7.7%)
Dec 1999
$6.81 M(+172.4%)
$6.81 M(+209.6%)
Sep 1999
-
$2.20 M(-8.3%)
Jun 1999
-
$2.40 M(-11.1%)
Mar 1999
-
$2.70 M(+8.0%)
Dec 1998
$2.50 M(0.0%)
$2.50 M(+25.0%)
Sep 1998
-
$2.00 M(-4.8%)
Jun 1998
-
$2.10 M(-8.7%)
Mar 1998
-
$2.30 M(-8.0%)
Dec 1997
$2.50 M(+31.6%)
$2.50 M(+13.6%)
Sep 1997
-
$2.20 M(+10.0%)
Jun 1997
-
$2.00 M(+25.0%)
Mar 1997
-
$1.60 M(0.0%)
Dec 1996
$1.90 M(+11.8%)
-
Nov 1996
-
$1.60 M(-5.9%)
Aug 1996
-
$1.70 M(0.0%)
Aug 1996
$1.70 M(-22.7%)
-
May 1996
-
$1.70 M(-32.0%)
Feb 1996
-
$2.50 M(+8.7%)
Nov 1995
-
$2.30 M(+4.5%)
Aug 1995
$2.20 M(-4.3%)
$2.20 M(-12.0%)
May 1995
-
$2.50 M(+25.0%)
Feb 1995
-
$2.00 M(-4.8%)
Nov 1994
-
$2.10 M(-8.7%)
Aug 1994
$2.30 M(-20.7%)
$2.30 M(-4.2%)
May 1994
-
$2.40 M(+9.1%)
Feb 1994
-
$2.20 M(-18.5%)
Nov 1993
-
$2.70 M(-6.9%)
Aug 1993
$2.90 M
$2.90 M(+31.8%)
May 1993
-
$2.20 M

FAQ

  • What is Anika Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Anika Therapeutics?
  • What is Anika Therapeutics annual total liabilities year-on-year change?
  • What is Anika Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Anika Therapeutics?
  • What is Anika Therapeutics quarterly total liabilities year-on-year change?

What is Anika Therapeutics annual total liabilities?

The current annual total liabilities of ANIK is $58.37 M

What is the all time high annual total liabilities for Anika Therapeutics?

Anika Therapeutics all-time high annual total liabilities is $93.20 M

What is Anika Therapeutics annual total liabilities year-on-year change?

Over the past year, ANIK annual total liabilities has changed by -$5.20 M (-8.18%)

What is Anika Therapeutics quarterly total liabilities?

The current quarterly total liabilities of ANIK is $51.54 M

What is the all time high quarterly total liabilities for Anika Therapeutics?

Anika Therapeutics all-time high quarterly total liabilities is $152.08 M

What is Anika Therapeutics quarterly total liabilities year-on-year change?

Over the past year, ANIK quarterly total liabilities has changed by -$6.13 M (-10.63%)